BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Business

  Supervisory Board Of Sartorius AG Extends Appointment Of The Group’s CEO Dr. Joachim Kreuzburg

  December 11, 2009

   · 

  1 min read
• Pharm Country

  Columbia Laboratories, Inc. Receives Nasdaq Notice of Non-Compliance with Minimum Bid Price Rule

  December 11, 2009

   · 

  1 min read
• BioMidwest

  Company Profile for Guardsman Scientific, Inc

  December 11, 2009

   · 

  1 min read
• BioMidwest

  Dynatronics Corporation Receives 180-Day NASDAQ Extension

  December 11, 2009

   · 

  1 min read
• Business

  MediGene AG Decides on a Revision of the Development Plans for EndoTAG(TM)-1 and RhuDex(TM), and Downsizes its Executive Board

  December 11, 2009

   · 

  3 min read
• Drug Development

  Pulmo BioTech Announces Status Update Regarding the Regulatory Approval Experiments and Phase I Trials for Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM)

  December 11, 2009

   · 

  4 min read
• Biotech Bay

  Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer

  December 11, 2009

   · 

  1 min read
• Deals

  Biogen Idec, Inc. (Massachusetts) Stands Ready to Close Its $17.50 Per Share All-Cash Tender Offer for Facet Biotech

  December 11, 2009

   · 

  1 min read
• Drug Development

  ThromboGenics NV Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)

  December 11, 2009

   · 

  1 min read
• Pharm Country

  Savient Pharmaceuticals, Inc. To Present at the 28th Annual JP Morgan Healthcare Conference

  December 11, 2009

   · 

  1 min read